Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine and hydrocortisone effects on memory accuracy and generalization
NL-OMON52476Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of atomoxetine and hydrocortisone (4 arms), sponsored by Radboud University Medical Center. Primary endpoint: Skin conductance response. Started May 2022; status: completed.
02
Drugs
atomoxetinehydrocortisone
Beyond the preview
Go deeper on NL-OMON52476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52476.